| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/17/2007 | CN1897949A Combination therapy comprising the use of et-743 and paclitaxel for treating cancer |
| 01/17/2007 | CN1897940A Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 01/17/2007 | CN1896229A Production of anti-CD20 intrinsic antibody and its use |
| 01/17/2007 | CN1896104A Fused protein for cell inhibitory factor and albumin |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896100A Liver regenerated factor and its use |
| 01/17/2007 | CN1896099A Zinc finger binding domains for gnn |
| 01/17/2007 | CN1896095A Lucid ganoderma sugar peptide, its production and use |
| 01/17/2007 | CN1896065A 1-(3', 4', 5'-tribasic-phenyl)-isoquinoline compound, its preparation and use |
| 01/17/2007 | CN1896064A Metabolites of ecteinascidin 743 |
| 01/17/2007 | CN1895676A Prodrug of taxol or polyene-taxol with carbowax as carrier |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895665A Scorpionfish-ink polysaccharide and its preparation |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/17/2007 | CN1895554A Chinese herb for inhibiting tumor and its preparation |
| 01/17/2007 | CN1895546A Lycium chinensis polyose medicinal composition with therapeutic and health-care functions |
| 01/17/2007 | CN1895524A Extraction of garlic volatile oil |
| 01/17/2007 | CN1895481A Chinese medicinal preparation for treating tumor |
| 01/17/2007 | CN1895479A Chinese medicine for treating cancer |
| 01/17/2007 | CN1895337A Pharmaceutical use of Tangshen and Milkvetch root composition for improving late tumor patient life quality |
| 01/17/2007 | CN1895302A Cercopithecoidealin with anti-tumor function, its preparation and use |
| 01/17/2007 | CN1895287A Medicine with antibacterial, antiviral, anticancer, antineoplastic, antianaphylaxis and anti-deficit functions |
| 01/17/2007 | CN1895262A Emulsion for injecting epirubicin and its production |
| 01/17/2007 | CN1895257A Use of 20(S)-protopanoxadiol in preparation of anti-bowelcancer medicine |
| 01/17/2007 | CN1895244A Medicinal composition for preventing and treating cancer diseases |
| 01/17/2007 | CN1895237A Officinal magnolia phenol lipid frozen dried powder preparation and its use in preparing drug for cancers |
| 01/17/2007 | CN1895220A 20(R)-ginseng sapoglycoside Rg3 medicinal soluble intermediate and its production |
| 01/17/2007 | CN1295340C Method for establishing polymorphism adenoid tumour mouse model |
| 01/17/2007 | CN1295339C Attenuated vaccinia virus Tiantan strain vector and its preparation and application |
| 01/17/2007 | CN1295338C Polytheneimine transgened carrier of targeted fibroblast growth factor receptor |
| 01/17/2007 | CN1295331C Oncogene, recombinant protein derived therefrom, and uses thereof |
| 01/17/2007 | CN1295247C Ganoderma lucidum polysaccharide protein and its preparing method and use |
| 01/17/2007 | CN1295245C Dengxin subergorgia saponin |
| 01/17/2007 | CN1295229C Crystals of taxane derivative and process for their production |
| 01/17/2007 | CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
| 01/17/2007 | CN1294988C Buckwheat trypsase inhibitor, expression and application thereof |
| 01/17/2007 | CN1294987C Use of cTn I in preparation of anticancer medicine |
| 01/17/2007 | CN1294975C Medicine for alleviating pain of cancer |
| 01/17/2007 | CN1294923C Use of ammopiptanthus ester in preparation of anti- liver cancer medicine |
| 01/17/2007 | CN1294909C Novel anti-biological cell free-radical oxidation injury mixture |
| 01/17/2007 | CN1294841C Health-care food for preventing cancer |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163946 Urogenital disorders; bleeding; hormone replacement therapy; anticancer agents; contraceptives |
| 01/16/2007 | US7163941 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 01/16/2007 | US7163940 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 01/16/2007 | US7163935 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/16/2007 | US7163680 Contacting vascular endothelial cells proximate to cancerous cells with the biological agent to permit both binding of biological agent to vascular endothelial cells proximate to cancerous cells and ablating or killing of cancerous cells |
| 01/16/2007 | CA2366065C Topical cosmetic composition comprising bifidobacterium and plant extracellular matrix |
| 01/16/2007 | CA2219742C N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 01/11/2007 | WO2007005863A1 Crystalline forms of (2r-trans)-6-chloro-5[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride |
| 01/11/2007 | WO2007005760A1 Methods of application of chemical compounds having therapeutic activities in treating cancers |
| 01/11/2007 | WO2007005708A1 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 01/11/2007 | WO2007005673A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/11/2007 | WO2007005670A2 Natural and synthetic sulfoxide, selenone and selenoxide analogs and polymer conjugated forms thereof for the modulation of angiogenesis |
| 01/11/2007 | WO2007005631A1 Pyrrolotriazine compounds useful as kinase inhibitors |
| 01/11/2007 | WO2007005630A1 Pyrrolotriazine compounds useful as kinase inhibitors |
| 01/11/2007 | WO2007005403A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| 01/11/2007 | WO2007004749A1 Fused heterocyclic derivatives and use thereof |
| 01/11/2007 | WO2007004733A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 01/11/2007 | WO2007004692A1 Prophylactic/therapeutic agent and diagnostic agent for non-small cell lung cancer |
| 01/11/2007 | WO2007004621A1 Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent |
| 01/11/2007 | WO2007004587A1 Malignant tumor cell suppressor protein, malignant tumor cell suppressor gene, malignant tumor cell suppressive viral vector, and kit using the same |
| 01/11/2007 | WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 01/11/2007 | WO2007004526A2 Identification of compounds modulating the smyd3 transferase for the treatment of cancer |
| 01/11/2007 | WO2007004390A1 Cachexia improving preparation and cachexia improving food |
| 01/11/2007 | WO2007004341A1 Rna-binding peptide |
| 01/11/2007 | WO2007004244A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 01/11/2007 | WO2007003944A2 Compounds for imaging and therapy |
| 01/11/2007 | WO2007003933A2 Combination therapy of cancer with azd2171 and gemcitabine |
| 01/11/2007 | WO2007003904A2 Prophylactic and immunomodulatory compositions and uses |
| 01/11/2007 | WO2007003765A1 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 01/11/2007 | WO2007003741A2 Polyphenol type compounds, compositions containing same and use thereof for preventing or treating diseases involving abnormal cell proliferation |
| 01/11/2007 | WO2007003612A1 Tumor restricted oncolytic virus with improved cell transduction spectrum |
| 01/11/2007 | WO2007003611A1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors |
| 01/11/2007 | WO2007003596A1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 01/11/2007 | WO2007003536A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 01/11/2007 | WO2007003426A1 Anti-ccr7 receptor antibodies for the treatment of cancer |
| 01/11/2007 | WO2007003216A1 Anti-ccr7 receptor antibodies for the treatment of cancer |
| 01/11/2007 | WO2007002973A2 Use of stilbene derivatives for the production of medicaments for the treatment of solid tumours |
| 01/11/2007 | WO2006124780A3 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase |
| 01/11/2007 | WO2006123182A3 Cyclohexyl sulphones for treatment of cancer |
| 01/11/2007 | WO2006117220A3 Method of administering a cationic liposomal preparation comprising paclitaxel |
| 01/11/2007 | WO2006113498A3 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases |
| 01/11/2007 | WO2006113151A3 Use of an epidermal growth factor receptor kinase inhibitor (egfr) in gefitinib resistant patients |
| 01/11/2007 | WO2006095173A3 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 01/11/2007 | WO2006094209A3 N-benzimidazolylalkyl-substituted amide sirtuin modulators |
| 01/11/2007 | WO2006088393A3 Method for producing an anti-cancer agent |
| 01/11/2007 | WO2006083979B1 Local treatment of neurofibromas |
| 01/11/2007 | WO2006083936A3 Anti-ephb2 antibodies and methods using same |
| 01/11/2007 | WO2006079731A3 Use of cacao polyphenols for treating a prostate hyperplasia, a specific cacao extract and applications |
| 01/11/2007 | WO2006078886A3 Compounds and compositions as wnt signaling pathway modulators |
| 01/11/2007 | WO2006061259A3 Cytotoxic agents comprising new c-2 modified taxanes |
| 01/11/2007 | WO2006061219A3 Il-7 variants with reduced immunogenicity |